Nintedanib CAS No.656247-17-5 Pharmaceutical Intermediates
Physical and Chemical Properties
- Molecular weight: 539.64 g/mol
- Appearance: The product is typically light yellow powder, indicating its purity and quality.
- Solubility: Nintedanib is soluble in organic solvents such as dimethyl sulfoxide (DMSO) and slightly soluble in water, making it easy to add to various formulations.
- Melting Point: Compounds have a melting point which ensures stability during storage and handling.
- Chemical stability: Nintedanib exhibits good chemical stability under standard conditions, which is critical for drug application.
1. Multi-target effect: Nintedanib inhibits multiple receptor tyrosine kinases, including VEGFR, FGFR and PDGFR, which play a key role in angiogenesis and fibrosis. This multi-target effect enhances its therapeutic effect.
2. Proven Effective: Clinical studies have shown that nintedanib can effectively slow the progression of idiopathic pulmonary fibrosis and improve the treatment prognosis of certain cancer patients.
3. Regulatory Compliance: Our manufacturing processes comply with international regulations, ensuring that our products are safe and effective in pharmaceutical applications.
4. Custom Synthesis: We provide custom synthesis services to meet specific customer requirements, providing tailor-made solutions for different pharmaceutical needs.
As a leading manufacturer and trader of chemical products, we pride ourselves on our commitment to quality and customer satisfaction. Our integrated approach allows us to control the entire production process, ensuring our customers receive only the best products. With a focus on innovation and sustainability, we are committed to meeting the ever-changing needs of the pharmaceutical industry.
Nintedanib is mainly used in the pharmaceutical industry for the following purposes:
- Treatment of Idiopathic Pulmonary Fibrosis (IPF): Nintedanib is approved for the treatment of IPF, a progressive lung disease characterized by scarring of lung tissue. It helps slow the decline of lung function.
- Oncology Applications: Nintedanib is also used to treat certain types of cancer, including non-small cell lung cancer (NSCLC) and other solid tumors, where it can inhibit tumor growth and metastasis.
- Research and Development: It is widely used in R&D laboratories to develop novel therapeutic agents for fibrotic diseases and cancer.
In conclusion, Nintedanib is a versatile and essential compound in the pharmaceutical industry. Its unique properties and benefits make it ideal for a wide range of applications, and our commitment to quality ensures that you receive a product that meets your highest standards. Contact us today to learn more about our products and how we can support your pharmaceutical needs.